Subscribe for real-time financial insights on Trade Target’s WhatsApp Channels
Nephro Care India Limited established in 2014 and leading healthcare provider based in Kolkata. The center specializes in renal care and offers a broad spectrum of clinical and lifestyle treatments focusing particularly on renal insufficiency.
Supported by team of expert doctors, seasoned paramedical professionals and efficient management they serves around 900 Chronic Kidney Disease patients each month. The hospital boasts dedicated staff including 5 permanent doctors, 10 visiting consultants and 70 experienced paramedical professionals.
It’s main clinic is in Salt Lake spread across 5,352 square feet, along with three satellite clinics located in Salt Lake (HB 113) and Chandannagar, West Bengal.
As of March 31, 2024 Nephro Care India Limited employs 110 professionals across various departments.
Nephro Care India IPO Overview
Nephro Care India is launching its IPO aiming to raise Rs 41.26 crores through fresh issue of 45.84 lakh shares. The IPO subscription opens on June 28, 2024 and closes on July 2, 2024. The allotment is expected to be finalized on July 3, 2024 with shares set to list on NSE SME on July 5, 2024. The price range for IPO is set between ₹85 to ₹90 per share and minimum application size is 1600 shares.
The company’s promoter, Dr. Pratim Sengupta, currently holds an 85.02% stake which will reduce to 61.39% post-issue. The registrar of this IPO is Bigshare Services Pvt Ltd.
Nephro Care India IPO GMP
Nephro Care India SME IPO’s latest grey market premium (GMP) is ₹100, as of 11:00 AM on June 28, 2024. Given the price band of ₹90, the estimated listing price is ₹190 (cap price + today’s GMP). This suggests an expected gain of 111.11% per share.
Stay tuned with Trade Target for daily updates on Nephro Care India IPO GMP and the expected listing price.
- Date: 3 – July – 2024
- Nephro Care India GMP:₹235 (261.11%)
- Date: 2 – July – 2024
- Nephro Care India GMP: ₹180 (200%)
- Date: 1 – July – 2024
- Nephro Care India GMP: ₹155 (172.22%)
- Date: 30 – June – 2024
- Nephro Care India GMP:₹120 (133.33%)
- Date: 29 – June – 2024
- Nephro Care India GMP:₹120 (133.33%)
- Date: 28 – June – 2024
- Nephro Care India GMP: ₹120 (133.33%)
- Date: 27 – June – 2024
- Nephro Care India GMP: ₹100 (111.11%)
- Date: 26 – June – 2024
- Nephro Care India GMP: ₹20 (22.22%)
How can one apply for Nephro Care India IPO?
Nephro Care India’s IPO requires investors to bid for a minimum of 1,600 shares. The table below shows the minimum and maximum investment amounts for retail investors and high-net-worth individuals (HNIs) in terms of shares and their corresponding investment amounts:
| Application | Lots | Shares | Amount |
|---|---|---|---|
Retail (Min) | 1 | 1600 | ₹144,000 |
Retail (Max) | 1 | 1600 | ₹144,000 |
S-HNI (Min) | 2 | 3200 | ₹288,000 |
Nephro Care India IPO Financial
Nephro Care India Limited has shown significant financial growth over the past three years. Here is a summary of their financial performance for the periods ending on March 31 of each year:
| Period Ended | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|
Assets in (₹ Lakhs) | 831.11 | 462.93 | 112.84 |
Revenue (₹ Lakhs) | 1,709.51 | 342.70 | 183.26 |
PAT (₹ Lakhs) | 194.24 | -0.98 | 8.87 |
Total Borrowing (₹ Lakhs) | 246.39 | 253.74 | 69.27 |
Nephro Care India IPO Quota allocation
- QIB Investor: 50% of the net issue
- Retail Investor: 35% of the net issue
- NII (HNI) Investor: 15% of the net issue
Expected Listing Date for Nephro Care India IPO
- Subscription Period: 28 June to 1 July
- Basis of Allotment Finalization: 2July 2024
- Initiation of Refunds: 3 July 2024
- Demat Credits: 4 July 2024
- Listing Date: 5 July 2024
- Listing on: NSE SME
